Results 261 to 270 of about 6,399,825 (302)
Some of the next articles are maybe not open access.

Dendritic/Tumor Fusion Cells as Cancer Vaccines

Seminars in Oncology, 2012
A promising cancer vaccine involves the fusion of dendritic cells (DCs) with tumor cells such that a broad array of tumor antigens are presented in the context of DC-mediated costimulation and stimulatory cytokines. In diverse animal models, vaccination with DC/tumor fusions results in protection from an otherwise lethal challenge of tumor cells and ...
David, Avigan   +2 more
openaire   +2 more sources

Therapeutic vaccination with tumor cells that engage CD137

Journal of Molecular Medicine, 2003
Therapeutic cancer vaccination is based on the finding that tumors in both humans and experimental animals, such as mice, express potential immunological targets, some of which have high selectivity for cancer cells. In contrast to the successful vaccination against some infectious diseases, where most vaccines induce neutralizing antibodies that act ...
Karl Erik, Hellstrom   +1 more
openaire   +2 more sources

Treatment of visceral tumor with BCG-tumor cell vaccine

Cancer Immunology, Immunotherapy, 1978
A vaccine containing irradiated tumor cells and BCG, previously shown to be effective against a contralateral, intradermal (ID) tumor inoculum, was also effective in suppressing or curing tumor deposited in the subcutaneous (SC) space or injected intravenously (IV).
Gerald L. Bartlett   +3 more
openaire   +1 more source

Gene-modified tumor cells as cellular vaccine

Cancer Immunology, Immunotherapy, 1996
The identification and characterization of many tumor antigens and the parallel explosion of knowledge of the cellular and molecular mechanisms of antigen recognition by the immune system have given renewed hopes that immunogenetherapy could be a promising modality to treat certain tumors.
openaire   +2 more sources

Whole tumor cell vaccine with irradiated S180 cells as adjuvant

Vaccine, 2009
Whole tumor cell vaccines have been widely studied and remain promising cancer immunotherapies. In the present study, we discovered that vaccination with irradiated mouse sarcoma S180 tumor cells stimulated robust antitumor immunity to autologous tumor cells in both syngenic and allogenic mice.
Jinhua, Li   +6 more
openaire   +2 more sources

Evaluation of Dendritic Cell–Tumor Cell Hybrid Vaccine Storage

Biopreservation and Biobanking, 2008
Clinical trials using dendritic cells (DCs) to treat cancer patients have generated promising results in recent years. However, even simple aspects of this therapy are still not well understood, including the storage and distribution of manufactured vaccines. These processes are essential and must be elucidated in order to reduce costs.
Juliana Moreira, de Sousa-Canavez   +4 more
openaire   +2 more sources

Construction strategies of whole tumor cell vaccines

Biomaterials Science
WTCVs sources include: autologous from patients, allogeneic, and lab-cultured cells. They are processed into multiple vaccine forms. The immunogenicity is enhanced via delivery systems, adjuvants, and gene editing to improve anti-tumor immunity.
Xilin Wang   +7 more
openaire   +2 more sources

Dendritic cell?tumor cell hybrid vaccination for metastatic cancer

Cancer Immunology, Immunotherapy, 2004
Dendritic cells are the most potent antigen-presenting cells, and the possibility of their use for cancer vaccination has renewed the interest in this therapeutic modality. Nevertheless, the ideal immunization protocol with these cells has not been described yet. In this paper we describe the preliminary results of a protocol using autologous tumor and
Jose Alexandre M, Barbuto   +9 more
openaire   +2 more sources

T Cells as Antigen Carriers for Anti-tumor Vaccination

2016
The exploitation of the physiologic processing and presenting machinery of dendritic cells (DCs) by in vivo loading of tumor-associated antigens may improve the immunogenic potential and clinical efficacy of DC-based cancer vaccines. The approach developed by our group was based on the clinical observation that some patients treated with the infusion ...
Traversari C., Russo V.
openaire   +3 more sources

Tumor Cell Vaccination for Gynecological Tumors

Hybridoma, 1993
V, Möbus   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy